(Q39766594)

14 September 2017

title

RNA interference inhibits hepatitis E virus mRNA accumulation and protein synthesis in vitro (English)

1 reference

14 September 2017

1 reference

1 reference

hepatitis E virus

1 reference

Fen Huang

1

1 reference

14 September 2017

Junfang Zhou

2

1 reference

14 September 2017

Zhibiao Yang

3

1 reference

14 September 2017

Li Cui

4

1 reference

14 September 2017

Wen Zhang

5

1 reference

14 September 2017

Congli Yuan

6

1 reference

14 September 2017

Shixing Yang

7

1 reference

14 September 2017

Jianguo Zhu

8

1 reference

14 September 2017

Xiuguo Hua

9

1 reference

14 September 2017

publication date

6 November 2009

1 reference

14 September 2017

published in

Veterinary Microbiology

1 reference

14 September 2017

volume

142

1 reference

14 September 2017

issue

3-4

1 reference

14 September 2017

page(s)

261-267

1 reference

Hepatitis E: an overview and recent advances in clinical and laboratory research.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Prevalence of anti-hepatitis E virus antibodies in different Indian animal species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Hepatitis E virus RNA in commercial porcine livers in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Molecular biology. RNAi safety comes under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Macaque models of human infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Routes of transmission of swine hepatitis E virus in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

7 January 2021

Silencing HIV-1 In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Hepatitis E vaccine--ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

siRNA efficiency: structure or sequence-that is the question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

More complete gene silencing by fewer siRNAs: transparent optimized design and biophysical signature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Inhibition of Henipavirus infection by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Presence of antibodies to hepatitis E virus in Japanese pet cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Effect of target secondary structure on RNAi efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Safety and efficacy of a recombinant hepatitis E vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Efficient recombinant hepatitis E virus vaccine: mission accomplished?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Development and evaluation of an efficient cell-culture system for Hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Zoonotic transmission of hepatitis E virus from deer to human beings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Serological evidence of hepatitis E virus infection in different animal species from the Southeast of Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2009.10.023

7 January 2021

inferred from DOI database lookup

Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells

1 reference

12 December 2020

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine

1 reference

12 December 2020

Viral hepatitis in travellers

1 reference

12 December 2020

Cell culture of sporadic hepatitis E virus in China.

1 reference

12 December 2020

Animal coronavirus vaccines: lessons for SARS.

1 reference

12 December 2020

10.1016/J.VETMIC.2009.10.023

Identifiers

DOI

1 reference

14 September 2017

1 reference